Victory Capital Management
NMTR

Victory Capital Management’s 9 Meters Biopharma NMTR Stock Holding History

Victory Capital Management’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,729
Closed -$9K – 2808
2022
Q2 		$9K Buy
1,729
+11
+0.6% +$104 ﹤0.01% 2661
2022
Q1 		$14K Sell
1,718
-86
-5% -$1.17K ﹤0.01% 2660
2021
Q4 		$35K Sell
1,804
-49
-3% -$1.1K ﹤0.01% 2661
2021
Q3 		$48K Sell
1,853
-68
-4% -$1.6K ﹤0.01% 2689
2021
Q2 		$42K Buy
1,921
+335
+21% +$8.22K ﹤0.01% 2676
2021
Q1 		$37K Buy
1,586
+12
+0.8% +$369 ﹤0.01% 2688
2020
Q4 		$27K Buy
1,574
+525
+50% +$8.76K ﹤0.01% 2491
2020
Q3 		$17K Buy
1,049
+313
+43% +$3.79K ﹤0.01% 2442
2020
Q2 		$8K Buy
736
+170
+30% +$1.92K ﹤0.01% 2477
2020
Q1 		$6K Buy
+566
New +$7.1K ﹤0.01% 3473
2019
Q4 		– Sell
-207
Closed -$4K – 3467
2019
Q3 		$4K Buy
+207
New +$4.18K ﹤0.01% 3530

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Victory Capital Management's NMTR Position: Q3 2022 in Review

Victory Capital Management sold out of 9 Meters Biopharma (NMTR) in Q3 2022, closing a stake of 1,729 shares — an estimated $9K sold.

Victory Capital Management first reported a position in NMTR in Q3 2019 and held it in 11 quarters. The position peaked at $48K in Q3 2021. 74 funds tracked by Wall St. Rank hold NMTR as of Q3 2022.

  • Victory Capital Management reported no remaining 9 Meters Biopharma position as of Q3 2022 after selling out during the quarter.
  • Victory Capital Management sold 1,729 9 Meters Biopharma shares in Q3 2022, an estimated $9K.
  • Victory Capital Management first reported a position in 9 Meters Biopharma in Q3 2019 and held it in 11 quarters.
  • Victory Capital Management's 9 Meters Biopharma position peaked at $48K in Q3 2021.
  • 74 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2022.

Based on Victory Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.